Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO)

Toxicology

Volumn 220, Issue 2-3, 2006, Pages 203-217

  Loveless, Scott E ^a   Finlay, Carol ^a   Everds, Nancy E ^a   Frame, Steven R ^a   Gillies, Peter J ^a   O'Connor, John C ^a   Powley, Charles R ^a   Kennedy, Gerald L ^a  

^a DUPONT COMPANY   (United States)

Author keywords

Ammonium perfluorooctanoate; APFO; Branched; Linear; Linear branched; PFOA

Indexed keywords

AMMONIUM DERIVATIVE; AMMONIUM PERFLUOROOCTANOIC ACID; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; PERFLUOROOCTANOIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BODY WEIGHT; CHEMICAL STRUCTURE; CONTROLLED STUDY; FATTY ACID OXIDATION; FOOD INTAKE; KIDNEY MASS; LIPID BLOOD LEVEL; LIVER WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TOXICITY TESTING;

ANIMALS; FLUOROCARBONS; KIDNEY; LIPIDS; LIVER; MICE; MICE, INBRED STRAINS; OCTANOIC ACIDS; ORGAN SIZE; OXIDATION-REDUCTION; PEROXISOMES; RATS; RATS, INBRED STRAINS; WEIGHT GAIN;

ANIMALIA;

EID: 33244485545     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.01.003     Document Type: Article

References (36)

1. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
2. J. Butenhoff, G. Costa, C. Elcombe, D. Farrar, K. Hansen, H. Iwai, R. Jung, G. Kennedy, P. Lieder, G. Olsen, and P. Thomford Toxicity of ammonium perfluorooctanoate (APFO) in male Cynomolgus monkeys after oral dosing for six months Toxicol. Sci. 69 2002 244 257
3. J.L. Butenhoff, D.W. Gaylor, J.A. Moore, G.W. Olsen, J. Rodricks, J.H. Mandel, and L.R. Zubel Characterization of risk for general population exposure to perfluorooctanoate Regul. Toxicol. Pharmacol. 39 2004 363 380
4. O.J. Dunn Multiple contrasts using rank sums Technometrics 6 1964 241 252
5. C.W. Dunnett New tables for multiple comparisons with a control Biometrics 20 1964 482 491
6. C.W. Dunnett Pairwise multiple comparisons in the unequal variance case J. Am. Statist. Assoc. 75 1980 796 800
7. J.M. Flaherty, P.C. Connolly, E.R. Decker, S.M. Kennedy, M.E. Ellefson, W.R. Reagen, and B. Szostek Quantitative determination of perfluorooctanoic acid (PFOA) in serum and plasma by liquid chromatography tandem mass spectrometry J. Chromatogr. B 819 2005 329 338
8. K.J. Hansen, L.A. Clemen, M.E. Ellefson, and H.O. Johnson Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices Environ. Sci. Technol. 35 2001 766 770
9. B. Haughom, and O. Spydevold The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid Biochim. Biophys. Acta 1128 1 1992 65 72
10. U. Intrasuksri, S.M. Rangwala, M. O'Brien, D.J. Noonan, and D. Feller Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids Gen. Pharmacol. 31 1998 187 197
11. 14C] perfluorooctanesulfonate Fund. Appl. Toxicol. 4 6 1984 972 976
12. K. Kalliomaa, M. Haag-Groenlund, and K. Victorin A new model function for continuous data sets in health risk assessment of chemicals using the benchmark dose concept Regul. Toxicol. Pharmacol. 27 1998 98 107
13. Y. Kawashima, H. Kobayashi, H. Miura, and H. Kozuka Characterization of hepatic responses of rat to administration of perfluorooctanoic and perfluorodecanoic acids at low levels Toxicology 99 3 1995 169 178
14. R.A. Kemper Perfluorooctanoic acid: toxicokinetics in the rat USEPA Administr. Rec. 2003 226 1499
15. G.L. Kennedy, J.L. Butenhoff, G.W. Olsen, J.C. O'Connor, A.M. Seacat, R.G. Perkins, L.B. Biegel, and S.R. Murphy The toxicology of perfluorooctanoate Crit. Rev. Toxicol. 34 2004 351 384
16. W.H. Kruskal, and W.A. Wallis Use of ranks in one-criterion analysis of variance J. Am. Statist. Assoc. 47 1952 583 621
17. N. Kudo, and Y. Kawashima Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals J. Toxicol. Sci. 28 2003 49 57
18. P.B. Lazarow Assay of peroxisomal β-oxidation of fatty acids Meth. Enzymol. 72 1981 315 319
19. H. Levene Robust test for equality of variances J. Olkin Contributions to Probability and Statistics 1960 Stanford University Press Palo Alto 278 292
20. E.K. Maloney, and E.J. Waxman Trans-activation of PPAR-α and PPAR-γ by structurally diverse environmental chemicals Toxicol. Appl. Pharmacol. 161 1999 209 218
21. G.W. Olsen, F.D. Gilliland, M.M. Burlew, J.M. Burris, J.S. Mandel, and H. Mandel An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid J. Occup. Environ. Med. 40 1998 614 620
22. G.W. Olsen, J.M. Burris, M.M. Burlew, and J.H. Mandel Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers Drug Chem. Toxicol. 23 2000 603 620
23. G.W. Olsen, J.M. Burris, M.M. Burlew, and J.H. Mandel Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations J. Occup. Environ. Med. 45 2003 260 270
24. G.W. Olsen, K.J. Hansen, L.A. Stevenson, J.M. Burris, and J.H. Mandel Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals Environ. Sci. Technol. 37 2003 888 891
25. S. Pack A Review of Statistical Data Analysis and Experimental Design in OECD Aquatic Toxicology Test Guidelines 1993 Shell Research Ltd., Sittingbourne Research Centre Sittingbourne, Kent, UK
26. S.R. Searle, G. Casella, and C.E. McCulloch Variance Components 1992 Wiley New York
27. K. See, and A.J. Baylor Added risk and inverse estimation for count responses in reproductive aquatic toxicology studies Biometrics 54 1998 67 73
28. S.S. Shapiro, and M.B. Wilk An analysis of variance test for normality (complete samples) Biometrika 52 1965 591 611
29. W. Slob Dose-response modeling of continuous endpoints Toxicol. Sci. 66 2002 298 312
30. G.W. Snedecor, and W.G. Cochran Statistical Methods 6th ed. 1967 The Iowa State University Press Iowa pp. 246-248 and 349-352
31. D. Taves, W. Guy, and W. Brey Organic fluorocarbons in human plasma: prevalence and characterization R. Filler Biochemistry Involving Carbon-Fluorine Bonds 1976 American Chemical Society Washington, DC 117 134
32. F.A. Ubel, S.D. Sorenson, and D.E. Roach Health status of plant workers exposed to fluorochemicals - a preliminary report Am. Ind. Hyg. Assoc. J. 41 1980 584 589
33. USEPA, 1995. The use of the benchmark dose approach in health risk assessment. EPA/630/R-94/007.
34. USEPA, 2002. Revised draft. Hazard assessment of perfluorooctanoic acid and its salts. USEPA Public Docket AR-226.
35. J. Vanden Heuvel, B. Kuslikis, and M. Van Rafelghem Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats Biochem. Toxicol. 6 1991 83 92
36. Y. Xie, Q. Yang, B.D. Nelson, and J.W. DePierre The relationship between liver peroxisome proliferation and adipose tissue atrophy induced by peroxisome proliferator exposure and withdrawal in mice Biochem. Pharmacol. 66 2003 749 756